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Background: Index admission laparoscopic cholecystectomy (ALC) is the treatment of choice for
patients admitted with biliary symptoms but is performed in less than 15% of these admissions. We
analysed our results for ALC within a tertiary hepatobiliary centre.
Methods: Data from all cholecystectomies carried out under the care of the two senior authors from
1998 to 2008 were prospectively collected and interrogated.
Results: 1710 patients underwent cholecystectomy of which 439 (26%) were ALC. Pateints operated on
acutely did not have a significantly different complication rate (P = 0.279; 4% vs.3%). Factors predicting
complications were abnormal alkaline phosphatase (ALP) (P = 0.037), dilated common bile duct (CBD) (P
= 0.026), cholangitis (P = 0.040) and absence of on table cholangiography (OTC) (P = 0.011). There were
no bile duct injuries. Patients undergoing ALC had a higher rate of conversion to an open procedure (P
< 0.001:10% vs.3%). The proportion of complicated disease was higher in the ALC group (P < 0.001; 70%
vs.31%). Only complicated disease (P = 0.006), absence of OTC (P < 0.001) and age greater than 65 years
(P < 0.001) were predictive of conversion on multivariate analysis.
Conclusions: Laparoscopic cholecystectomy can be performed safely in patients with acute biliary
symptoms and should be considered the gold standard for management of these patients thus avoiding
avoidable readmissions and life-threatening complications. A higher conversion rate to an open proce-
dure must be accepted when treating more complicated disease. It is the severity of disease rather than
timing of surgery which most probably predicts complications and conversions.
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Introduction
Laparoscopic cholecystectomy is one of the most common opera-
tions performed in the Western World with more than 49 000
operations performed each year in England alone.1 It is the opera-
tion of choice for patients who present with acute biliary symp-
toms,2,3 for which there are more than 25 000 acute admissions in
England alone each year.4 Patients may suffer symptoms of biliary
colic, acute cholecystitis, cholangitis, acute pancreatitis or other
less common gallstone-related pathologies necessitating acute
admission to hospital.
It is intuitive that after acute presentation, the sooner the defini-
tive management, the better for the patient. Delaying the opera-
tion results in a plethora of unwanted consequences for both
patient and hospital. Recurrent painful symptoms are common
and these lead to further hospital attendance for many, reported to
be as high as one hospital visit per patient waiting for operation.5
Further, it has been reported that 17% of patients will require
readmission because recurrent symptoms are so severe.4 In addi-
tion, a proportion of these patients subsequently develop more
severe disease such as acute pancreatitis.6–8 A recent study reported
that acute laparoscopic cholecystectomy (ALC) was performed in
less than 15% of patients admitted with acute biliary symptoms
in the UK.4 Reasons for such a low rate included a perceived
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increased complication rate, lack of appropriately trained sur-
geons and lack of a properly resourced emergency theatre.
We aimed to explore and compare the results of laparoscopic
cholecystectomy for patients admitted with acute biliary symp-
toms who had ALC on index admission with all those patients
who had elective laparoscopic cholecystectomy (ELC) in a special-
ist hepatobiliary centre over the past 10 years.
Methods
Data were prospectively collected from every cholecystectomy
performed under the care of the two senior authors between 1998
and June 30th 2008. Both are Hepato-pancreatico-biliary special-
ists at St James’s University Hospital, Leeds, performing approxi-
mately 30% of the cholecystectomies carried out in the trust.
Prospectively collected data including patient demographics,
diagnoses, pre-operative investigations and interventions, opera-
tive details, post-operative investigations and interventions, his-
tology and outcomes were collated and analysed. Patients were
classified as having ‘complicated’ disease if the clinical diagnosis
was cholecystitis, gallstone pancreatitis, jaundice or cholangitis, or
in the presence of raised liver function tests outwith laboratory
reference ranges, or in the presence of ultrasound findings of a
dilated biliary tree or a thick walled gallbladder. Jaundice was
defined clinically. Patients with a diagnosis of biliary colic and
with normal pre-operative investigations were classified as
‘uncomplicated’ disease.
Patient selection
Currently approximately 550 cholecystectomies are carried out
annually in the Leeds NHS trust. Of these, 150 are done acutely
out of approximately 300 annual acute hospital admissions with
biliary symptoms. Since 2000, St James’ University Hospital has
offered an ALC service. It has been the policy of the two senior
authors to perform ALC for all patients admitted with acute
biliary symptoms if patient fitness permitted.
Surgical technique
Cholecystectomies were carried out over a 10-year period hence
practice has evolved over this time. Four ports were used routinely
with Strasberg’s ‘critical view of safety’ fully dissected out before
clipping the cystic artery or duct.9 On table cholangiography
(OTC) was routinely used, except when unavailability of radiol-
ogy equipment or radiographers, short or friable cystic ducts or
other technical difficulties prevented its use.
The need for pre-operative magnetic resonance cholangiopan-
creatography (MRCP) and endoscopic retrograde cholangiopan-
creatography (ERCP) has fallen with improved endoscopic
availability and increased use of intra-operative bile duct explo-
ration. Common bile duct (CBD) stones identified on OTC were
managed by both senior authors by laparoscopic transcystic
retrieval in the first instance, and if unsuccessful, by laparoscopic
or open CBD exploration, or post-operative ERCP depending on
clinical circumstances.
Statistics
Non-parametric data are presented as median (range), with cat-
egorical data presented as a frequency and proportion (%).
Univariate analysis was performed to assess for any significant
differences in outcome measure among patients. Categorical data
were analysed using Pearson’s c2-test. Continuous variables were
analysed using the Mann–Whitney U-test. A multivariate analysis
was performed for significant variables on univariate analysis. All
statistical tests were carried out using SPSS forWindows™ version




In total 1710 cholecystectomies were performed under the care
of the two surgeons of which 439 (26%) were carried out
acutely. The number of acute and elective cholecystectomies per
year is shown in Fig. 1. The ALC programme was commenced in
2001 and plateaued, peaking in 2004. The numbers of ALC
carried out in the two authors’ practice has dropped slightly
since then as a result of a combination of increasing ALC by
other surgeons and service reconfiguration with more upper gas-
trointestinal specialists being employed at St James’s University
Hospital.
Acute vs. elective
The acute group had a higher proportion of male patients (P =
0.029; 28% vs. 23%) although both groups had similar numbers of
older (>65 years; 76% vs. 77%) patients (median age 52 years in
elective group and 53 years in acute) (Table 1). As would be
expected the acute patients had more ‘complicated disease’, with
significantly higher proportions of acute patients presenting with
clinical jaundice (P < 0.001; 11% vs. 8%), cholecystitis (P < 0.001;
31% vs. 13%), acute pancreatitis (P < 0.001; 20% vs. 5%) and
cholangitis (P = 0.002; 8% vs. 4%). Conversely, the majority of the
elective group were patients with a diagnosis of biliary colic (P <
0.001; 30% vs. 69%). Further, pre-operative blood tests were more
likely to be abnormal for alanine aminotransferase (ALT) (41% vs.
19%), alkaline phosphatase (ALP) (30% vs. 6%) and bilirubin
(19% vs. 5%) in the acute group (all P < 0.001). Ultrasound
imaging of acute patients was more likely to show a dilated
common bile duct (CBD) (P < 0.001; 20% vs. 9%), stones in the
CBD (P = 0.042; 5% vs. 4%), intrahepatic bile duct dilatation (P <
0.001; 5% vs. 1%) and a thickened gallbladder wall (P < 0.001;
21% vs. 11%). Again as would be expected, patients operated on
acutely were significantly more likely to require a conversion from
a laparoscopic to an open procedure (P < 0.001; 10% vs. 3%).
However, despite all this, there was no significant difference in the
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complication rate (see Table 2) between patients managed elec-
tively and those acutely (P = 0.279; 4% vs. 3%).
Length of stay
Patients operated on acutely had a longer median length of stay (P
< 0.001; 6 vs. 2 days) and a significantly longer pre-operative
waiting time between admission and surgery (P < 0.001; 3 vs. 0
days).
Complications
There were a total of 60 patients with complications (3.5%)
(Table 2). Wound infection (n = 11) was the most common com-
plication followed by chest infections (n = 9). There were no bile
duct injuries although there were seven bile leaks from the gall-
bladder bed and four cystic duct leaks. Post-operative bile leaks
were managed with either percutaneous drainage or ERCP and
stent. There was one death in our series in a patient operated on
electively who had a post-operative myocardial infarction and
subsequent stroke. A prolonged pre-operative wait was not asso-
ciated with an increased risk of complications.
Among the total of 1710 patients, a presentation of cholangitis
(P = 0.040), abnormal ALP (0.037), dilated CBD (P = 0.026) and
no OTC (P = 0.011) were significant at predicting complications
amongst patients undergoing cholecystectomy (Table 3). On mul-
tivariate analysis none of the variables maintained significance
although the absence of OTC approached this (P = 0.059)
(Table 3).
Although not classed as a complication, 11 out of 439 acute
patients (2.5%) and 33 out of 1271 elective patients (2.6%)
patients required a post-operative ERCP with or without stent
placement to clear CBD stones. In addition, six patients with
clinical suspicion of CBD stones but in whom an OTC was not
possible received a post-operative MRCP (0.4%).
Conversion to an open procedure
Factors predictive of conversion to an open procedure were acute
presentation (P < 0.001), male gender (P < 0.001), age over 65 (P
< 0.001), cholecystitis (P = 0.001), a thickened gallbladder wall (P
= 0.003) and all the factors related to the presence of bile duct
stones; jaundice (P = 0.003), cholangitis (P = 0.002), an abnormal
ALP (P < 0.001), a dilated CBD (P < 0.001), dilated intrahepatic
ducts (P = 0.011) and transcystic bile duct exploration (P = 0.027)
(Table 3). Presentation with biliary colic had a significantly lower
risk of conversion (P < 0.001). However, on multivariate analysis,
only the absence of OTC (P < 0.001, HR 1.79–5.22) and age
greater than 65 years (P < 0.001 HR 1.57–4.52) predicted
increased risk of conversion to an open operation (Table 3), with
a presentation of biliary colic indicating a decreased risk of con-
version (P = 0.006, HR 0.16–0.74). Of the 84 patients requiring
conversion, 18 (21%) were to facilitate bile duct stone extraction.
Histology
The histology results for acute and elective patients were broadly
similar (Table 4).
Discussion
Separate Cochrane reviews have concluded that ALC is the treat-
ment of choice for patients presenting with biliary colic and acute
cholecystitis,2,3 demonstrating that definitive treatment on index
admission reduces morbidity, risk of conversion, operative time
and hospital stay. However, these reviews included only one ran-
domised controlled trial (RCT; n = 75) in the biliary colic review
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Figure 1 Numbers of acute and elective cholecystectomy by year
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concluded that further evidence was required. While our study
group of 1710 patients has not been randomized, it does support
the view that patients presenting with acute biliary symptoms can
be managed safely with ALC.
Our results confirm that ALC can be carried out without
increased patient complication rates, without bile duct injuries
and with a zero mortality rate. This is despite the ALC group
having a higher proportion of patients with cholecystitis, jaun-
Table 1 Differences between groups operated on electively and acutely
Variable Elective (n = 1271) Acute (n = 439) P-value
Gender 0.029
Female 984 (77%) 317 (72%)
Male 287 (23%) 122 (28%)
Age 0.455
>65 239 (23%) 77 (24%)
<65 801 (77%) 245 (76%)
Presentation
Biliary colic 831 (69%) 122 (30%) <0.001
Jaundice 91 (8%) 45 (11%) <0.001
Cholecystitis 161 (13%) 125 (31%) <0.001
Pancreatitis 57 (5%) 79 (20%) <0.001
Cholangitis 54 (4%) 31 (8%) 0.002
Asymptomatic 16 (1%) 0 0.029
Pre-operative bloods
Abnormal ALT 241 (19%) 180 (41%) <0.001
Abnormal ALP 83 (6%) 134 (30%) <0.001
Abnormal bilirubin 59 (5%) 84 (19%) <0.001
Pre-operative imaging
CBD stones 45 (4%) 22 (5%) 0.042
Dilated CBD 115 (9%) 90 (20%) <0.001
Dilated IHD 8 (1%) 20 (5%) <0.001
Thick GB wall 138 (11%) 92 (21%) <0.001
ERCP 80 (6%) 29 (7%) 0.818
ERCP intervent. 49 (4%) 19 (4%) 0.662
MRCP 79 (6%) 29 (7%) 0.772
HIDA 45 (4%) 3 (0.7%) 0.006
Operative details
Laparoscopic 1219 (96%) 418 (95%) 0.536
Converted 42 (3%) 42 (10%) <0.001
No OTC 231 (18%) 104 (24%) 0.005
Registrar operated 111 (9%) 81 (18%) <0.001
Trancystic explor. 46 (4%) 23 (5%) 0.029
Lap CBD explor. 10 (1%) 1 (0.2%) 0.207
Open CBD explor. 20 (2%) 1 (0.2%) 0.030
Post-operative complications 41 (3%) 19 (4%) 0.279
Length of stay
Total stay 2 (0–34) 6 (1–34) <0.001
Pre-operative stay 0 (0–26) 3 (0–31) <0.001
Post-operative stay 1 (0–32) 2 (0–22) <0.001
ALT, alanine aminotransferase; ALP, alkaline phosphatise; CBD, common bile duct; explor, exploration; GB, gallbladder; HIDA, hepatobiliary
iminodiacetic acid; intervent, intervention; IHD, intrahepatic ducts; ERCP, endoscopic retrograde cholangiopancreatography; MRCP, magnetic
resonance cholangiopancreatography; OTC, on table cholangiography.
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dice, pancreatitis and cholangitis. In our series it is primarily the
severity of the underlying disease process rather than the timing of
surgery that determines need for conversion. Our complication
rates (elective 3%, acute 4%) and conversion rates (3% elective,
10% acute) compare favourably with other large series. The
number of laparoscopic cholecystectomies performed under the
care of the two senior authors has diminished since 2007, after
restructuring of surgical services in Leeds and the employment of
additional Upper GI surgeons at St James’ University Hospital.
It is important to remember that conversion to an open proce-
dure is not necessarily ‘surgical failure’. Whilst a cholecystectomy
completed laparoscopically, safely, is better for the patient for a
multitude of reasons, in particular a quicker return to normal
activities,10 continuing laparoscopically when it is unsafe to do so
in order to maintain low conversion rates may put the patient at
risk of bile duct injury and other complications. Of course, high
conversion rates that outlie that of one’s peers may still put the
surgeon’s level proficiency into question.Morbidity and mortality
should therefore always be examined alongside conversion rate as
primary outcomemeasures when evaluating outcome from chole-
cystectomy. One without the other can be misleading.
Comparisons of rates of complication, bile duct injury and
conversion have led some to suggest that better results are
achieved in higher volume units.11,12 We agree that a high volume
caseload is required to maintain the skills required to produce the
best results which are particularly important when operating on
acute patients. There have been no single centre studies published
with comparable numbers of patients to ours and so we have
compared our results with registry data although this has the
known disadvantage of possibility of coding errors. A Swiss reg-
istry analysis of 22 953 patients showed an elective complication
rate of 11% and an acute complication rate of 25%13 and a Dutch
series of 1254 patients showed complication rates of 7% with an
18% conversion rate amongst a mixed group of acute and elective
patients.14 Recently, a British series drawn from HES data of all
43 821 patients undergoing laparoscopic cholecystectomy in the
UK in 2005–06 has shown conversion rates of 4.6% for elective
procedures and 9.4% for acute procedures.11 This series, however,
involves a large number of surgeons, with differing patient selec-
tion policies for acute surgery and differing operative practices.
These results are not directly comparable to ours, in which a high
percentage of patients receive ALC irrespective of severity of
disease, and where the vast majority of operations were performed
or supervised by one of two experienced hepatobiliary surgeons.
Similarly, without discussion of complication rates, the clinical
significance of their conversion rates is difficult to interpret.
Those who are against carrying out ALC argue mainly that the
inflammatory process occurring during an acute presentation
leads to a more difficult procedure and greater complications.15
However, patients admitted to hospital with acute biliary symp-
toms managed conservatively are more likely to be readmitted
with further attacks of acute pain, resulting in further time absent
from work. Indeed, some cases will develop more complicated
disease6–8 which we have shown leads to higher complication rates.
This can be avoided by performing ALC during the first acute
admission and we have shown here that ALC can be performed
safely.
Our data have shown that patients operated on acutely have
longer in-patient stays but this was largely because of the longer
pre-operative wait. Our data did not include waiting time from
decision to operate to surgery, and for acute cases our data could
therefore be skewed by patients who waited several days for
surgery after a decision had been made to operate. A separate
12-month internal audit of admissions in our unit has shown that
more than one-third of patients admitted acutely wait 4 or more
days from the time of being booked for theatre to having their
surgery. As a result we are investigating changes in ALC service
configuration to shorten this waiting time. Historically it has been
suggested that there is only a short window of opportunity to
perform ALC.16 However, our data shows that under the care of
experienced hepatobiliary surgeons, pre-operative wait prior to
surgery was not associated with increased rates of complication or
conversion.Although registrars performed a greater proportion of
acute than elective cases (18% vs. 9%), in fact, the majority of
registrars performing ALC were post-CCT fellows with Consult-
ant supervision in all cases.
As would be expected,11 we found that complicated disease was
a risk factor for conversion. We also found increased conversion
rates in older patients. Older patients tend to present with more
severe disease because of a relative immunosuppresion,17 and are
known to have ‘baggier’ biliary trees which will likely put them at
higher risk of having bile duct pathology therefore higher risk of
conversion.Unfortunately we did not prospectively collect data on
previous abdominal surgery which would also likely affect con-
version rates.
The use of OTC remains controversial. However, several studies
have shown that use of OTC reduces number and severity of bile
duct injuries.18,19 Further, it has been shown that routine use of
OTC is cost-effective because of its effect in reducing complica-
tions.20 In our series, OTC was not performed in 19.6% of patients
Table 2 Post-operative complications
Acute (19) Elective (41)
Wound infection 5 Chest infection 6
Chest infection 3 Wound infection 6
Cystic duct leak 2 Bile leak 5
Bile leak 2 Bleeding 4
Bleeding 1 Acute urinary retention 3
Others 6 Collection 2
Herniae 2
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as a result of unavailability of a radiographer or imaging equip-
ment, technical difficulties, or when a short friable cystic duct
precluded use of OTC. Our series has shown that in patients who
did not undergo OTC, the complication and conversion rates were
higher. This is consistent with previous reports which suggest that
surgeons who routinely use OTC have slightly higher complica-
tion rates in their group of patients where it was not possible to
perform OTC, but lower complication rates in both their OTC
and non-OTC groups than those surgeons who do not routinely
performOTC.21,22 Various explanations have been put forward but
our experience would suggest that when OTC is not carried out, it
is either in patients whose biliary anatomy is not clearly identifi-
able, and therefore necessitating conversion before the stage of
performing OTC, or in patients where the anatomy is identifiable
Table 3 Factors predictive of complications or conversion
Variable Complications (n = 60) Conversions (n = 84)
Univariate Multi-variate Univariate Multi-variate
P-value P-value
Gender
Female 0.250 <0.001‡ 0.330
Age
>65 0.153 <0.001 <0.001
Acute operation 0.279 <0.001 0.143
Presentation
Biliary colic 0.209 <0.001‡ 0.006‡
Jaundice 0.279 0.007 0.840
Cholecystitis 0.390 <0.001 0.311
Pancreatitis 0.117 0.304
Cholangitis 0.040 0.327 0.002 0.219
Asymptomatic 0.646 0.683
Pre-op bloods
Abnormal ALT 0.981 0.215
Abnormal ALP 0.037 0.347 <0.001 0.555
Abnormal bilirubin 0.363 0.056
Pre-op imaging
CBD stones 0.661 0.035 0.325
Dilated CBD 0.026 0.236 <0.001 0.891
Dilated IHD 0.393 0.011 0.862
Thick GB wall 0.512 0.003 0.780
ERCP 0.680 <0.001 0.462
ERCP intervent. 0.431 <0.001 0.409





No OTC 0.011 0.059 <0.001 <0.001
Registrar operated 0.190 0.903
Trancystic explor. 0.267 0.027 0.069
Lap CBD explor. 0 0.207
Open CBD explor. 0.745 –
Post-operative complications – 0.519
Length of stay
Pre-opertive stay 0.155 <0.001 0.912
Significant factors are highlighted in bold. Note ‡implies significant decreased risk of conversion. See Table 1 for list of abbreviations.
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but OTC would be technically difficult such as with a short, friable
cystic duct. In both situations the disease severity predisposes to
increased risk of complications compared with patients who have
an uncomplicated gallbladder. The correlation between absence of
OTC and greater complications therefore likely reflects overall
difficulty of procedure, rather than direct causation due to omis-
sion of OTC. Because of this, the advantage of confirming biliary
anatomy prior to division of cystic duct, and the opportunity to
identify and retrieve CBD stones intra-operatively rather than
with additional postoperative ERCP, our unit continues to advo-
cate routine use of OTC in all cases.
In conclusion, we have shown in a large series of patients that
despite operating on patients with more ‘complicated disease’,
ALC can be performed safely. This should be considered the gold
standard for the management of patients with acute biliary symp-
toms and will lead to a reduction in readmissions and avoidable
complications.
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